The VAXDIAX antibody test after COVID-19 vaccinations has been developed to detect the status of highly specific neutralizing antibodies against SARS-CoV-2.
The test, which is CE-marked and manufactured in Germany, provides a test result in 5-10 minutes, depending on the titer strength, based on the WHO reference value for analytical sensitivity of 35 BAU/ml.
BacTrace BioTec AG works closely with a renowned and decorated Scientific Advisory Board as well as with internationally recognized universities and scientific institutions.
Prof. Dr. Dr. h.c. mult. Willi Jäger, Universität Heidelberg
Dipl.-Ing. Manfred Opel, Brigade General a.D.
Prof. Dr. Valentin N. Pavlov, Bashkir State Medical University
Priv.-Doz. Dr. med. Michael T. Pawlik, Universität Regensburg
Dr. med. Sören Wagner, Harvard Medical School
Prof. Dr. med. Dr. h.c. mult. Wolf F. Wieland, Universität Regensburg
Dr. med. Hans Hermann Wörl
Contact
BacTrace BioTec AG Autharistrasse 31 81545 Munich Germany